Reaction
Joint Hyperextension reporting signals
As of the last recalculation, Joint Hyperextension appears in 389 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is CAPTOPRIL (PRR 57.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Captopril | 10 | 57.1 | 57.1 |
| Valproate Sodium | 19 | 51.7 | 51.7 |
| Felodipine Extended-Release Tablets | 10 | 48.2 | 48.2 |
| Felodipine | 10 | 48.2 | 48.2 |
| Nebivolol | 10 | 34.5 | 34.5 |
| Nevirapine | 5 | 30.0 | 30.0 |
| Asfotase Alfa | 5 | 27.0 | 27.1 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 25.0 | 25.0 |